These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10644865)

  • 1. Elevation of serum levels of metalloproteinase-1, tissue inhibitor of metalloproteinase-1 and type IV collagen, and plasma levels of metalloproteinase-9 in polycystic kidney disease.
    Nakamura T; Ushiyama C; Suzuki S; Ebihara I; Shimada N; Koide H
    Am J Nephrol; 2000; 20(1):32-6. PubMed ID: 10644865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
    Tayebjee MH; Nadar S; Blann AD; Gareth Beevers D; MacFadyen RJ; Lip GY
    Am J Hypertens; 2004 Sep; 17(9):764-9. PubMed ID: 15363817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy.
    Rysz J; Banach M; Stolarek RA; Pasnik J; Cialkowska-Rysz A; Koktysz R; Piechota M; Baj Z
    J Nephrol; 2007; 20(4):444-52. PubMed ID: 17879211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.
    Ulrich D; Hrynyschyn K; Pallua N
    Plast Reconstr Surg; 2003 Oct; 112(5):1279-86. PubMed ID: 14504511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrosis of extracellular matrix is related to the duration of the disease but is unrelated to the dynamics of collagen metabolism in dilated cardiomyopathy.
    Rubiś P; Wiśniowska-Śmialek S; Wypasek E; Biernacka-Fijalkowska B; Rudnicka-Sosin L; Dziewiecka E; Faltyn P; Khachatryan L; Karabinowska A; Kozanecki A; Tomkiewicz-Pająk L; Podolec P
    Inflamm Res; 2016 Dec; 65(12):941-949. PubMed ID: 27516211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating biochemical marker levels of collagen metabolism are abnormal in patients with abdominal aortic aneurysm.
    Nakamura M; Tachieda R; Niinuma H; Ohira A; Endoh S; Hiramori K; Makita S
    Angiology; 2000 May; 51(5):385-92. PubMed ID: 10826855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of low-density lipoprotein apheresis on plasma matrix metalloproteinase-9 and serum tissue inhibitor of metalloproteinase-1 levels in diabetic hemodialysis patients with arteriosclerosis obliterans.
    Nakamura T; Matsuda T; Suzuki Y; Ueda Y; Koide H
    ASAIO J; 2003; 49(4):430-4. PubMed ID: 12918586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension.
    Tayebjee MH; Karalis I; Nadar SK; Beevers DG; MacFadyen RJ; Lip GY
    Am J Hypertens; 2005 Mar; 18(3):325-9. PubMed ID: 15797648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary disease.
    Navratilova Z; Zatloukal J; Kriegova E; Kolek V; Petrek M
    Respirology; 2012 Aug; 17(6):1006-12. PubMed ID: 22591289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
    Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
    Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artesunate modulates expression of matrix metalloproteinases and their inhibitors as well as collagen-IV to attenuate pulmonary fibrosis in rats.
    Wang Y; Huang G; Mo B; Wang C
    Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum tissue inhibitor of matrix metalloproteinase-1 levels are associated with mortality in patients with malignant middle cerebral artery infarction.
    Lorente L; Martín MM; Ramos L; Cáceres JJ; Solé-Violán J; Argueso M; Jiménez A; Borreguero-León JM; Orbe J; Rodríguez JA; Páramo JA
    BMC Neurol; 2015 Jul; 15():111. PubMed ID: 26162891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basement membrane remodeling in skeletal muscles of patients with limb ischemia involves regulation of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases.
    Baum O; Ganster M; Baumgartner I; Nieselt K; Djonov V
    J Vasc Res; 2007; 44(3):202-13. PubMed ID: 17337906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum levels of type I collagen degradation marker ICTP and tissue inhibitor of metalloproteinase (TIMP) 1 are associated with poor prognosis in lung cancer.
    Ylisirniö S; Höyhtyä M; Mäkitaro R; Pääakkö P; Risteli J; Kinnula VL; Turpeenniemi-Hujanen T; Jukkola A
    Clin Cancer Res; 2001 Jun; 7(6):1633-7. PubMed ID: 11410500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of MMP-9 and TIMP-1 in primary hypertension and effect of antihypertensive treatment.
    Onal IK; Altun B; Onal ED; Kirkpantur A; Gul Oz S; Turgan C
    Eur J Intern Med; 2009 Jul; 20(4):369-72. PubMed ID: 19524176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in lung and breast cancer are altered during chest radiotherapy.
    Susskind H; Hymowitz MH; Lau YH; Atkins HL; Hurewitz AN; Valentine ES; Meek AG; Zucker S
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1161-9. PubMed ID: 12829155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia.
    Lorenzl S; Buerger K; Hampel H; Beal MF
    Int Psychogeriatr; 2008 Feb; 20(1):67-76. PubMed ID: 17697439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities of the extracellular degradation of collagen type I in essential hypertension.
    Laviades C; Varo N; Fernández J; Mayor G; Gil MJ; Monreal I; Díez J
    Circulation; 1998 Aug; 98(6):535-40. PubMed ID: 9714110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modulation of aberrant extracellular matrix degradation systems by astragali radix and angelicae sinensis radix decoction (A&A) in interstitial fibrotic kidney].
    Meng L; Liao A; Qu L; Tang J; Li X
    Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(1):79-84. PubMed ID: 22741467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?
    Marín F; Roldán V; Climent V; Garcia A; Marco P; Lip GY
    Stroke; 2003 May; 34(5):1181-6. PubMed ID: 12663879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.